Headquartered in Monheim (Germany), Cube is a leading provider of both products and services that allow for samples of purified, highly stable membrane proteins to be obtained. These play a key role as receptors for new drugs but they are extremely difficult to extract without loss of native functionality.
Founded in 2012, Cube is now recognized as a highly reputable and recognized player in its sector and serves a diversified client base, comprising some of the top 10 Big Pharma companies. Cube has also strengthened its position in North America with the opening in 2013 of a subsidiary in Wayne (United States).
Location: Germany, North Rhine-Westphalia, Monheim am Rhein
Investors 2
| Date | Name | Website |
| - | ArchiMed | archimed.g... |
| - | Creathor V... | creathor.c... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 18.10.2023 | Is Membrane Protein Research the Future of Pharmaceutical In... | As we look at the biotech industry, one particular domain emerges as a promising focus of future inn... | eustartup.... |
| 04.11.2021 | Google Cloud goes deep into financial services with $1 billi... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 04.11.2021 | Google Cloud goes deep into financial services with $1 billi... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| - | Successful Exit for Creathor Ventures – ArchiMed buys Cube B... | Bad Homburg, 3.11.2021 – Creathor Ventures announced that the trans-atlantic private equity healthca... | creathor.c... |